Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Following Up on Bristol-Myers Squibb's Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Following Up on Bristol-Myers Squibb's Restructuring Plans, Company to Shift 1,250 Workers Out of N.J. Site" ALT"Following Up on Bristol-Myers Squibb's Restructuring Plans, Company to Shift 1,250 Workers…

Continue ReadingFollowing Up on Bristol-Myers Squibb's Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site

Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-research.jpg" NAME"Chinese Billionaire's Biotech Hutchison China MediTech Shows Off Phase III Cancer Drug Data" ALT"Chinese Billionaire's Biotech Hutchison China MediTech Shows Off Phase III Cancer Drug Data"March 3, 2017By…

Continue ReadingChinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data

Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal3.jpg" NAME"Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune" ALT"Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune"March 3, 2017By Mark Terry, BioSpace.com Breaking...…

Continue ReadingSanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune